Neuberger Berman Group’s Esperion Therapeutics ESPR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14K | Buy |
14,250
+1,894
| +15% | +$1.86K | ﹤0.01% | 2033 |
|
|
2025
Q1 | $17.8K | Buy |
12,356
+1,635
| +15% | +$2.35K | ﹤0.01% | 1938 |
|
|
2024
Q4 | $23.6K | Hold |
10,721
| – | – | ﹤0.01% | 1902 |
|
|
2024
Q3 | $17.7K | Buy |
+10,721
| New | +$17.7K | ﹤0.01% | 1898 |
|
|
2023
Q3 | – | Sell |
-15,899
| Closed | -$22.1K | – | 1828 |
|
|
2023
Q2 | $22.1K | Buy |
+15,899
| New | +$22.1K | ﹤0.01% | 1769 |
|
|
2018
Q2 | – | Sell |
-18,000
| Closed | -$1.3M | – | 1717 |
|
|
2018
Q1 | $1.3M | Buy |
+18,000
| New | +$1.3M | ﹤0.01% | 1106 |
|
|
2017
Q3 | – | Sell |
-16,500
| Closed | -$764K | – | 1605 |
|
|
2017
Q2 | $764K | Buy |
+16,500
| New | +$764K | ﹤0.01% | 1210 |
|
|
2015
Q3 | – | Sell |
-20,341
| Closed | -$1.66M | – | 1542 |
|
|
2015
Q2 | $1.66M | Buy |
20,341
+12,466
| +158% | +$1.02M | ﹤0.01% | 1103 |
|
|
2015
Q1 | $729K | Buy |
+7,875
| New | +$729K | ﹤0.01% | 1268 |
|
|
2013
Q4 | – | Sell |
-22,550
| Closed | -$425K | – | 1625 |
|
|
2013
Q3 | $425K | Buy |
+22,550
| New | +$425K | ﹤0.01% | 1347 |
|